Otulfi 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FRWD0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,248
Award facts
- Contract value 100% obligated
- $2,248.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $2,248.28 to DMS Pharmaceutical Group Inc. for Otulfi 90 mg/ml syringes on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price delivery order was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing comprehensive pharmaceutical products and medical consumables to Department of Defense facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. That master contract, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The master contract authorizes firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, biologics, and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide, enabling DMS Pharmaceutical Group to serve as a critical pharmaceutical supplier for Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FRWD0?
SPE2DR26FRWD0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FRWD0 worth?
The government has obligated $2,248 on SPE2DR26FRWD0.
Is contract SPE2DR26FRWD0 an order under another contract?
Yes. SPE2DR26FRWD0 is a delivery order under SPE2DR25D9767, an indefinite delivery contract.
Was contract SPE2DR26FRWD0 competed?
The extent of competition for SPE2DR26FRWD0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award